XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash provided by (used for) operating activities    
Net income $ 567 $ 603
Provision for (benefit from) Deferred Income Tax (37) 47
Net Periodic Pension and OPEB benefit, net (71) (318)
Pension and OPEB Contributions (55) (84)
Net loss (gain) on sales of property, businesses, consolidated companies, and investments 3 0
Restructuring and Asset related charges, net 5 100
Other net loss 104 54
Accounts and notes receivable (2,372) (2,012)
Inventories 234 467
Accounts Payable (406) (448)
Deferred Revenue (782) (401)
Other Assets and Liabilities (227) (262)
Cash provided by (used for) operating activities (2,730) (1,950)
Cash provided by (used for) investing activities    
Capital expenditures (179) (137)
Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested 5 20
Investments in and loans to nonconsolidated affiliates (6) 0
Purchases of investments (234) (40)
Proceeds from Sale and Maturities of Investments 10 194
Other investing activities - net 0 (1)
Cash provided by (used for) investing activities (404) 36
Cash provided by (used for) financing activities    
Net change in borrowings (less than 90 days) 744 828
Proceeds from debt 311 419
Repurchase of Common Stock (235) (350)
Proceeds from Exercise of Stock Options 40 38
Dividends paid to stockholders (102) (97)
Other financing activities (44) (17)
Cash provided by (used for) financing activities 714 821
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash (31) (50)
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash (2,451) (1,143)
Cash, Cash Equivalents and Restricted Cash at Beginning of Period 4,836 3,873
Cash, Cash Equivalents and Restricted Cash at End of Period [1] 2,385 2,730
EID [Member]    
Cash provided by (used for) operating activities    
Net income 560 592
Depreciation and Amortization 307 304
Provision for (benefit from) Deferred Income Tax (37) 47
Net Periodic Pension and OPEB benefit, net (71) (318)
Pension and OPEB Contributions (55) (84)
Net loss (gain) on sales of property, businesses, consolidated companies, and investments 3 0
Restructuring and Asset related charges, net 5 100
Other net loss 104 54
Accounts and notes receivable (2,372) (2,012)
Inventories 234 467
Accounts Payable (406) (448)
Deferred Revenue (782) (401)
Other Assets and Liabilities (217) (247)
Cash provided by (used for) operating activities (2,727) (1,946)
Cash provided by (used for) investing activities    
Capital expenditures (179) (137)
Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested 5 20
Investments in and loans to nonconsolidated affiliates (6) 0
Purchases of investments (234) (40)
Proceeds from Sale and Maturities of Investments 10 194
Other investing activities - net 0 (1)
Cash provided by (used for) investing activities (404) 36
Cash provided by (used for) financing activities    
Net change in borrowings (less than 90 days) 744 828
Repayments of Related Party Debt (337) (447)
Proceeds from debt 311 419
Proceeds from Exercise of Stock Options 40 38
Other financing activities (47) (21)
Cash provided by (used for) financing activities 711 817
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash (31) (50)
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash (2,451) (1,143)
Cash, Cash Equivalents and Restricted Cash at Beginning of Period 4,836 3,873
Cash, Cash Equivalents and Restricted Cash at End of Period 2,385 2,730
Total company [Member]    
Cash provided by (used for) operating activities    
Depreciation and Amortization 307 304
Restructuring and Asset related charges, net 5 100
Total company [Member] | EID [Member]    
Cash provided by (used for) operating activities    
Depreciation and Amortization 307 304
Restructuring and Asset related charges, net $ 5 $ 100
[1] See page 14 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in interim Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows.